Q1 2016 13F Holders as of 3/31/2016
-
Type / Class
-
Equity / American Depositary Shares, each representing 1 Ordinary Shares
-
Shares outstanding
-
100M
-
Number of holders
-
43
-
Total 13F shares, excl. options
-
6.47M
-
Shares change
-
-586K
-
Total reported value, excl. options
-
$178M
-
Value change
-
-$18.3M
-
Number of buys
-
16
-
Number of sells
-
-25
-
Price
-
$27.50
Significant Holders of Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares (CLLS) as of Q1 2016
55 filings reported holding CLLS - Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares as of Q1 2016.
Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares (CLLS) has 43 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.47M shares
of 100M outstanding shares and own 6.44% of the company stock.
Largest 10 shareholders include FMR LLC (3.51M shares), Cormorant Asset Management, LLC (469K shares), ORBIMED ADVISORS LLC (350K shares), Tekla Capital Management LLC (310K shares), LAZARD ASSET MANAGEMENT LLC (259K shares), FRANKLIN RESOURCES INC (244K shares), Artal Group S.A. (210K shares), TAUBE HODSON STONEX PARTNERS LLP (170K shares), CLOUGH CAPITAL PARTNERS L P (161K shares), and Abingworth LLP (100K shares).
This table shows the top 43 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.